Arca
Skip to content
Tools
Tools

Chronic pancreatitis

Drug research and approvals for chronic pancreatitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 47 studies of chronic pancreatitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 5 open orphan designations naming it.

  • Recruiting worldwide: 47
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 47 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 3

Phase 2 6

Phase 1 or earlier 6

How its trials ended

229 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 42 whose ending is known, 33% met their primary endpoint, 7% missed it and 60% stopped early.

  • Completed, result not reported9039%
  • Ongoing6729%
  • Status unknown3013%
  • Met its primary endpoint146%
  • Stopped: other or unclear146%
  • Stopped: enrollment or feasibility63%
  • Missed its primary endpoint31%
  • Stopped: lack of efficacy21%
  • Stopped: sponsor or business decision21%
  • Stopped: safety1<1%

FDA orphan designations

Approved first, then open designations, newest first
Oct 22, 2025Camostat mesilateTreatment of chronic pancreatitisPangenix Pharma LimitedDesignated
Jul 1, 2024ProglumideTreatment of chronic pancreatitisCCKr Therapeutics. Inc.Designated
Sep 9, 2020ProglumideTreatment of Chronic PancreatitisRNR BioMedical Inc.Designated
Sep 5, 2019PEGylated recombinant human tumor necrosis factor-related…Treatment of chronic pancreatitis.Theraly Fibrosis, Inc.Designated
May 18, 2011CamostatTreatment of chronic pancreatitisNIXS CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.